Research programme: stroke therapies - PhylogicaAlternative Names: PYC-35T; PYC-36S
Latest Information Update: 20 Apr 2010
At a glance
- Originator Phylogica
- Class Peptide fragments
- Mechanism of Action Apoptosis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 18 Aug 2005 The programme is available for licensing (http://www.phylogica.com)
- 19 Jul 2004 Early research in Stroke in Australia (IV-injection)